Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case report

Malignant pleural mesothelioma (MPM) remains a deadly disease with limited therapeutic options beyond platinum/pemetrexed chemotherapy. Immune checkpoint inhibitors have demonstrated modest benefit in the second to later-line settings. An MPM patient from our institute developed myocarditis and myos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lie, Gabrielle, Weickhardt, Andrew, Kearney, Leighton, Lam, Que, John, Thomas, Liew, David, Arulananda, Surein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225145/
https://www.ncbi.nlm.nih.gov/pubmed/32420076
http://dx.doi.org/10.21037/tlcr.2020.02.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225145/
https://www.ncbi.nlm.nih.gov/pubmed/32420076
http://dx.doi.org/10.21037/tlcr.2020.02.05

Ejemplares similares